BBCC -7 Program Overview

​Program Overview

The Breast Center of Excellence of the Naef K. Basile Cancer Institute at the American University of Beirut Medical Center (AUBMC) organizes its 7th Annual Breast Cancer Conference, Beirut BBCC7, bringing together the Lebanese Order of Physicians, Lebanese Order of Nurses, Lebanese Order of Pharmacists, various Lebanese and Arab medical associations and non-governmental organizations,​​​​ and Lebanese and International experts collaborating together in the fight against breast cancer. The program includes updates on breast cancer patient assessment and treatment planning, management of chemotherapy side effects, breast conservative surgery, breast reconstruction, new advances in chemotherapy, anti-HER2 targeted therapy and hormonal therapy and ovarian function suppression, CDK4/6 inhibitors, Checkpoint Inhibitors Immunotherapy, PARPi, as well as new research abstracts, as well as two pharmacy and NGO workshops. 


Lebanese and International experts will share new knowledge, discuss novel advances in screening, loco-regional and systemic assessment, diagnosis, neoadjuvant therapy, surgery of the breast and axilla, radiation therapy, chemotherapy, targeted therapy, hormonal therapy, patient advocacy and support groups, as well as pharmacological and nursing aspects of care of patients with breast cancer.

Target Audience

This annual scientific meeting has been designed for physicians, researchers, scientists, physicians-in-training and medical students, as well as pharmacists, nurses, patient advocates. Breast cancer basic and clinical researchers, policymakers, and research promoters/funders are also encouraged to attend.


This symposium complies with the Lebanese Order of Physicians Continuing Medical Education, the Lebanese Order of Pharmacists, the Order of Nurses in Lebanon and the ANCC guidelines.

American University of Beirut Medical Center is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The planning committee and presenters declare no conflict of interest, including financial interest in product or company presented, direct research support, or other form of potential bias.